Related by context. All words. (Click for frequent words.) 66 nasopharyngeal carcinoma 65 Epstein Barr Virus EBV 63 leiomyoma 63 colorectal carcinoma 63 Hutchinson Gilford progeria 63 HLA DQ2 63 colorectal adenocarcinoma 63 DNA methylation patterns 62 renal carcinoma 62 Sjögren syndrome 62 pancreatic adenocarcinoma 62 Epstein Barr Virus 62 kidney urologic 62 carcinoid tumors 62 paraganglioma 62 epithelial tumors 62 myelofibrosis polycythemia vera 61 cisplatin resistant 61 paragangliomas 61 GPC5 61 Leukemias 61 oncogenesis 61 SSc 61 malignant lymphomas 61 GRP# 61 gastric carcinoma 61 hypermethylated 61 prostate carcinoma 61 gastric cancers 61 papillary renal cell carcinoma 61 clinicopathologic 61 herpesviruses 61 Chronic lymphocytic leukemia 61 hamartomas 60 cervical lymph nodes 60 essential thrombocythemia 60 pituitary adenomas 60 lung carcinomas 60 radiosensitive 60 ovarian pancreatic 60 FGFR3 60 choriocarcinoma 60 BRAF V#E 60 metastatic lymph nodes 60 tissue fibrosis 60 colon pancreatic 60 malignant prostate 60 gastric adenocarcinoma 60 Dysregulation 60 neuroendocrine cancers 60 ductal adenocarcinoma 60 IL#R 60 ccRCC 60 lymphangiogenesis 60 oligodendrogliomas 60 gene rearrangements 60 inherited mutations 60 epithelioid 60 LHRH receptor positive 60 antibody mediated 60 extramedullary 60 myopathies 59 Metastatic 59 fibrogenesis 59 urothelial carcinoma 59 DLX5 59 Wnt signaling pathway 59 breast cancer metastasis 59 bronchogenic carcinoma 59 embryonal rhabdomyosarcoma 59 carcinoid 59 Adenocarcinoma 59 Cholangiocarcinoma 59 immunohistochemical staining 59 CagA 59 genetic aberrations 59 neurofibromas 59 prostate carcinomas 59 axon guidance 59 promoter hypermethylation 59 immunocompetent 59 hyperplastic 59 sickle cell hemoglobin 59 neoplastic diseases 59 epigenetic modification 59 prostate cancer CaP 59 BMP4 59 ependymoma 59 primary hyperparathyroidism 59 neoplastic 59 malignant lymphoma 59 metastatic neuroendocrine tumors 59 lysosomal storage diseases 59 desmoplastic 59 MMP9 58 Histologically 58 NSCLC tumors 58 myeloproliferative neoplasms 58 pleomorphic 58 neural crest 58 pleural mesothelioma 58 synaptogenesis 58 Epstein Barr virus EBV 58 haematopoietic 58 CDH1 58 Myelodysplastic syndrome 58 molecular abnormalities 58 Meningiomas 58 somatostatin receptors 58 neurofibroma 58 oncogenic transformation 58 cholangiocarcinoma 58 pancreatic gastric 58 Nedd4 58 Medulloblastoma 58 mucinous 58 ovarian colon 58 pancreatic endocrine 58 lymphoid cells 58 synovial sarcoma 58 hepatoma 58 neurofibromatosis type 58 HER2 neu 58 epithelial cancers 58 ADPKD 58 cathepsins 58 androgen receptor AR 58 dyskeratosis congenita 58 breast carcinomas 58 1 diabetes T1D 58 histological subtype 58 FTLD 58 BCL#A 58 KRAS oncogene 58 Metastases 58 papillary thyroid carcinoma 58 renal cell carcinomas 58 pulmonary metastasis 58 molecular subtypes 58 IgG1 antibody 58 oncoprotein 58 neuroendocrine carcinoma 58 pancreatic lung 58 MALT lymphoma 58 Cryptococcus neoformans 58 STK# gene 58 fibromatosis 58 carcinoid tumor 58 hemophagocytic lymphohistiocytosis 58 colorectal gastric 58 RRM1 58 medulloblastomas 58 Rap1 58 thymic carcinoma 58 motor neuron degeneration 58 Basal cell 57 CYT# potent vascular disrupting 57 APOL1 57 peritoneal carcinomatosis 57 IGFBP2 57 Cyclin E 57 prostate adenocarcinoma 57 cell adhesion molecule 57 Dr. Victor Velculescu 57 p# mutations 57 Peutz Jeghers syndrome 57 trastuzumab resistant 57 aneuploidies 57 Fas ligand 57 urothelial cancer 57 Prognostic factors 57 malignant pleural mesothelioma 57 P cadherin 57 breast cancer subtypes 57 transgenic mouse models 57 mitochondrial disorders 57 muscular dystrophies 57 nasopharyngeal cancer 57 gastrointestinal stromal tumors GISTs 57 testicular germ cell 57 myotonic dystrophy 57 DNA methyltransferases 57 RNA splicing 57 ERBB2 57 germline mutation 57 Glioma 57 apoptotic pathway 57 idiopathic myelofibrosis 57 myeloproliferative disorders 57 glomerulonephritis 57 Upregulation 57 IDH mutations 57 GATA3 57 epigenetic mechanisms 57 metastatic bladder 57 pancreatic islet cell 57 papillary carcinoma 57 colon carcinoma 57 mycosis fungoides 57 Papillary 57 astrocytomas 57 Carcinoid 57 WT1 57 PNET 57 activin 57 transcriptional repressor 57 Endometrial cancer 57 schwannomas 57 haplotyping 57 Six3 57 interferon pathway 57 kinase inhibition 57 Acute myeloid leukemia 57 sarcomatoid 57 Malignant mesothelioma 57 FGFR2 57 nonmetastatic 57 ectopic expression 57 ERK1 2 57 proto oncogene 57 Myelodysplastic Syndrome 57 Clusterin 57 MEF2A 57 Hurthle cell 57 Haptoglobin 57 DIPG 57 tumoral 57 Glioblastoma Multiforme GBM 57 #q#.# [001] 57 Metastasis 57 breast endometrial 57 nutlin 3a 57 transcriptional regulation 56 Smac mimetic 56 underlying molecular mechanisms 56 breast pancreatic 56 T1c 56 vimentin 56 chronic granulomatous disease 56 esophagogastric junction 56 ovarian lung 56 blastoma 56 acute myeloid 56 neurite outgrowth 56 Rb#/p# 56 epithelial tissues 56 clefting 56 Carcinoid tumors 56 Kufs disease 56 inherited neurological disorder 56 adrenocortical cancer 56 chronic myeloid 56 hematopoietic cell 56 Waldenstrom macroglobulinemia 56 melanocytic 56 unresectable tumors 56 Fibrosis 56 interstitium 56 KRAS mutation 56 PCNSL 56 susceptibility loci 56 Wiskott Aldrich syndrome 56 JMML 56 protein misfolding diseases 56 uveal melanoma 56 Helicobacter pylori infection 56 tumor metastasis 56 rhabdoid 56 thoracic aortic disease 56 TMEM#B 56 KRAS mutant 56 actin remodeling 56 regulates gene expression 56 HER2 receptor 56 malignant fibrous histiocytoma 56 cAMP signaling 56 fascin 56 lymphoid tissue 56 histological subtypes 56 poly ADP ribose polymerase 56 prostate bladder 56 leiomyomas 56 genomic alterations 56 pRb 56 cell adhesion molecules 56 endocrine dysfunction 56 TACI mutations 56 lymph node enlargement 56 B7 H3 56 MSH2 56 smoldering myeloma 56 PIK3CA 56 Candida infection 56 prognostic markers 56 microdeletions 56 Cell Non Hodgkin 56 primitive neuroectodermal tumor 56 pulmonary hypertension PH 56 seminomas 56 miRNA expression 56 Chronic Lymphocytic Leukemia 56 HGPS 56 Myocarditis 56 epithelial cells lining 56 susceptibility alleles 56 prognostic indicator 56 idiopathic PAH 56 STK# [002] 56 sortilin 56 Human Leukocyte Antigen 56 mutated p# 56 Micro RNAs 56 HOTAIR 56 osteochondroma 56 familial pancreatic cancer 56 chromosomal mutations 56 microRNA expression 56 IDH1 mutation 56 transplantation HCT 56 neuroblastomas 56 Smad3 56 fatal neurodegenerative disorder 56 N. gonorrhoeae 56 diagnostic biomarker 56 Wilms tumors 56 thymidylate synthase TS 56 osteosarcomas 56 Gliomas 56 ovarian breast 56 hematological diseases 56 testicular tumors 56 metastatic gastric 56 malignant pancreatic 56 Relapsed Refractory 56 NKX#.# 56 systemic scleroderma 56 homodimers 56 hereditary spastic paraplegia 56 MYCN amplification 56 basal cells 55 BRAF V#E mutation 55 gastrointestinal stromal tumor 55 etiologic 55 progressive neurodegenerative disorders 55 clonogenic 55 neuroblastoma tumor 55 MT1 MMP 55 trophoblasts 55 EGF receptor 55 ovarian germ 55 FGFR1 55 mesenchymal cell 55 colorectal lung 55 mtDNA mutations 55 Hepatocellular Carcinoma HCC 55 metaplasia 55 metastatic colorectal 55 lymphoproliferative disorders 55 alveolar rhabdomyosarcoma 55 osteoclast 55 noncoding RNAs 55 lymphoid 55 HNPCC 55 PKCi 55 autoinflammatory diseases 55 ADAM# 55 benign neoplasms 55 pilocytic astrocytomas 55 humanized antibody 55 neuromuscular junction 55 transgene expression 55 COX2 55 carcinoma HCC 55 LRRK2 gene 55 Hashimoto thyroiditis 55 lymphoma leukemia 55 cirrhosis liver failure 55 TTR amyloidosis 55 epithelia 55 beta subunit 55 PTPN# 55 Multiple Myeloma MM 55 LIS1 55 pulmonary metastases 55 Hedgehog signaling 55 imatinib resistance 55 bladder carcinoma 55 cell signaling pathways 55 intracellular pathogens 55 Acute Renal Failure 55 bladder cancers 55 angiogenesis inhibition 55 Duchenne muscular dystrophy DMD 55 neuro endocrine 55 podocyte 55 beta1 integrin 55 Sezary syndrome 55 CP CPPS 55 fibrous dysplasia 55 leiomyosarcoma 55 ovarian endometrial 55 Barrett mucosa 55 histone modifications 55 pDC 55 Genetic variants 55 EGFr 55 Basal Cell 55 Acute Leukemia 55 NPM1 55 Meckel Gruber 55 colorectal liver 55 FGFs 55 vascular endothelial 55 chemoresistant 55 familial ALS 55 ocular disorders 55 liver metastasis 55 Alport syndrome 55 E#F# 55 commercialize deforolimus 55 Li Fraumeni syndrome 55 gene amplification 55 synovial cells 55 NKG2D 55 K ras mutations 55 somatic mutations 55 Notch signaling pathway 55 cervical breast 55 EGF receptors 55 lung adenocarcinoma 55 EGFR inhibitors 55 premalignant lesions 55 epithelial cell 55 Gastric cancer 55 node metastasis 55 TRAIL induced apoptosis 55 RAS RAF MEK 55 HNSCC 55 metastasis 55 discoid lupus 55 Genetic variations 55 cypin 55 lymphocytic 55 squamous cell cancer 55 adipogenic 55 neoplasms 55 chromophobe 55 biliary cancer 55 renal fibrosis 55 telomere maintenance 55 tumor suppressor protein 55 node metastases 55 Idiopathic Pulmonary Fibrosis 55 Sjogren syndrome 55 costimulation 55 malignancies 55 malignant phenotype 55 basal cell carcinoma BCC 55 Glioblastoma Multiforme 55 branching morphogenesis 55 atypical hemolytic uremic syndrome 55 neoplastic lesions 55 Metastatic breast cancer 55 supratentorial 55 Helicobacter 55 surface glycoprotein 55 LRP5 55 tumorigenicity 55 chemoresistance 55 GSTP1 55 Wnt beta catenin 55 activating mutation 55 lymphoid organs 55 Squamous Cell Carcinoma 55 metastatic cancer 55 chromosome aberrations 55 squamous cell lung cancer 55 Squamous cell 55 NKX2 55 lymphoproliferative disorder 55 causative genes 55 nonhereditary 55 genomic profiling 55 malignant ovarian 55 familial amyloidotic polyneuropathy FAP 55 Introgen ADVEXIN 55 breast carcinoma 55 Squamous 55 PDGFR 55 inherited retinal degeneration 55 Ets2 55 hepatocellular carcinoma 55 serine protease 55 Langerhans cell histiocytosis 55 NF1 55 transfusion syndrome 54 necrotizing pneumonia 54 AA Amyloidosis 54 germline mutations 54 fatal neuromuscular disorder 54 JAK2 gene 54 malignant pleural mesothelioma MPM 54 papillary RCC 54 malignant pheochromocytoma 54 orchitis 54 esophageal squamous cell carcinoma 54 TLE3 54 PTEN mutations 54 transmembrane protein 54 RUNX3 54 p#NTR 54 hereditary predisposition 54 motor neuron diseases 54 Metastatic colorectal cancer 54 proliferative disorders 54 lung metastasis 54 cellular pathways 54 carcinoma 54 hereditary deafness 54 neuroendocrine tumors 54 eIF 4E 54 myositis 54 Wegener granulomatosis 54 TGFß 54 stage IIIA 54 IDH1 mutations 54 prostate cancer PCa 54 malignant transformation 54 Lymph node 54 renal tumors 54 IGF IR 54 MYH9 gene 54 Mantle Cell Lymphoma 54 fibrocytes 54 oncoproteins 54 Necrotizing fasciitis 54 humanised antibody 54 TGF beta signaling 54 cystic lesions 54 lung adenocarcinomas 54 proapoptotic 54 carcinogenesis 54 Philadelphia Chromosome Positive 54 fibrotic disease 54 Chronic myeloid leukemia CML 54 CEACAM1 54 signaling cascades 54 Glioblastoma multiforme 54 Uterine cancer 54 carcinomas 54 geldanamycin 54 myelogenous leukemia 54 antisense RNA 54 microRNA molecules 54 Hodgkin lymphoma HL 54 nonalcoholic steatohepatitis NASH 54 mutated K ras 54 heritable disorders 54 primary immunodeficiencies 54 ceroid lipofuscinosis NCL 54 histologic subtype 54 neuropsychiatric disorder 54 Hurler syndrome 54 Niemann Pick disease 54 PCa 54 Moyamoya disease 54 angiosarcoma 54 trans retinoic acid 54 metastatic pancreatic 54 uPAR 54 fronto temporal dementia 54 hypermethylation 54 PI3K AKT 54 Myasthenia gravis 54 lymphoid tumors 54 progressive neurodegenerative disorder 54 prognostic marker 54 squamous carcinoma 54 CMV infections 54 adhesion molecule 54 mutational status 54 metastatic adenocarcinoma 54 endometrial adenocarcinoma 54 TTR gene 54 pancreatic neuroendocrine 54 deCODE ProstateCancer TM 54 mitochondrial fusion 54 metastatic cancers 54 lung fibrosis 54 T#I [002] 54 neoplasm 54 ependymomas 54 peroxisome 54 pituitary adenoma 54 pheochromocytomas 54 neuroendocrine 54 Hutchinson Gilford Progeria Syndrome 54 cytogenetic abnormalities 54 genetic polymorphism 54 pheochromocytoma 54 neuroblastoma tumors 54 hematologic disorders 54 histologies 54 metastatic carcinoma 54 cardiac channelopathies 54 serous ovarian cancer 54 lipomas 54 mesotheliomas 54 amyloid deposition 54 mastocytosis 54 Severe Combined Immunodeficiency 54 mediated apoptosis 54 deacetylation 54 leukemia myeloma 54 TGF ß 54 myelomas 54 endometrial cancers 54 teratoma 54 NFkB 54 maternally inherited 54 pancreatic colon 54 Adenomas 54 Methylation 54 achromatopsia 54 NF kappaB activation 54 anaplastic 54 panobinostat 54 GNAQ 54 genetic determinants 54 Aurora kinase 54 operable breast cancer 54 Brugada Syndrome 54 anemias 54 radiographic findings 54 C. trachomatis 54 multigene 54 JAK mutations 54 hepatic lesions 54 Myelofibrosis 54 Acute Myeloid Leukaemia AML 54 c MYC 54 optica 54 Lafora disease 54 seminoma 54 distant metastasis 54 chromosomal translocation 54 beta thalassemia 54 hypoxia inducible factor 54 hamartoma 53 myeloproliferative 53 ErbB2 positive 53 thyroid carcinoma 53 SOD1 gene 53 adrenocortical carcinoma 53 trophoblast 53 mitogen activated protein kinase 53 chronic periodontitis 53 EGFR receptor 53 primary biliary cirrhosis 53 thymoma 53 Glioblastoma 53 chromosomal instability 53 pseudotumor cerebri 53 Crigler Najjar syndrome 53 Oncogenes 53 kidney fibrosis 53 molecular mimicry 53 MELAS 53 hypereosinophilic syndrome 53 metastatic malignant melanoma 53 leukemias lymphomas 53 LRP6 53 invasive lobular 53 lung pancreatic 53 IRF6 53 GBMs 53 LVNC 53 precancerous condition 53 LHON 53 GISTs 53 premalignant 53 oesophageal adenocarcinoma 53 metachronous 53 gastrointestinal malignancies 53 FLT3 53 genetic syndromes 53 Li Fraumeni 53 Non Hodgkins lymphoma 53 induces apoptosis 53 TG2 53 Becker muscular dystrophy 53 MGUS 53 NMIBC 53 EoE 53 Diffuse Large B 53 neurodevelopmental disorder 53 neuronal cell 53 demyelinating diseases 53 protein kinases 53 microtubule dynamics 53 sporadic ALS 53 chronic eosinophilic leukemia 53 Hypophosphatasia 53 Pulmonary fibrosis 53 percutaneous biopsy 53 colorectal cancer CRC 53 uPA 53 postoperative delirium 53 nonmelanoma 53 Pleural mesothelioma 53 proteoglycan 53 invasive carcinoma 53 nodal metastasis 53 miRNA profiling 53 Glioblastoma multiforme GBM 53 hematological malignancy 53 amyloid protein plaques 53 PC# cells 53 multiple myeloma MM 53 Gleevec resistant 53 Carcinoma 53 membranous nephropathy 53 EGFR mutant 53 ras gene 53 cancerdefine 53 PARP inhibition 53 Polycythemia vera 53 hematologic malignancy 53 HbF 53 monoclonal gammopathy 53 PDGFRA 53 osteochondromas 53 tests miRview TM 53 acute leukemias 53 lymphomas leukemias 53 TMPRSS2 ERG fusion 53 atypical hyperplasia 53 osteopetrosis 53 lymphoblastic lymphoma 53 myogenesis 53 scleroderma 53 distinct subtypes 53 histologically 53 #q# deletion 53 thyroid hormone receptor 53 HER2 positive breast 53 costimulatory 53 tumor necrosis 53 frontotemporal dementia 53 Phenotypes 53 aerodigestive tract 53 pancreatic prostate 53 endostatin 53 oral squamous cell 53 Parkinson Disease PD 53 prostate carcinogenesis 53 biliary tract cancer 53 carcinoids 53 chronic lymphocytic 53 tumor subtypes 53 aberrant activation 53 immunotherapeutic approaches 53 pre malignant lesions 53 Nephrogenic Systemic Fibrosis NSF 53 Fanconi Anemia 53 hereditary degenerative 53 metastatic malignant 53 hematopoietic malignancies 53 radiochemotherapy 53 chromosomal aberrations 53 kinase pathway 53 etiologies 53 Surgical resection 53 lymphoid malignancies 53 axillary lymph nodes 53 allograft rejection 53 mosaicism 53 EBV infection 53 bladder tumors 53 precursor lesions 53 polycystic kidneys 53 estrogen receptor alpha 53 MAPK pathway 53 meningiomas 53 oncogenic mutations 53 NF2 53 antigen receptor 53 aneuploid cells 53 hepatocellular carcinoma HCC 53 B Cell Lymphoma 53 Hepatocellular Carcinoma 53 theranostics 53 antibody MAb 53 nonsmall cell lung cancer 53 cytologically 53 ER alpha 53 ectodermal dysplasia 53 Malignant Melanoma 53 esophageal carcinoma 53 pancreatic carcinoma 53 miR #a [002] 53 cell acute lymphoblastic 53 congenital hyperinsulinism 53 arterial calcification 53 presymptomatic 53 UHCMC 53 Wnt proteins 53 Velculescu 53 penile cancers 53 HBeAg negative 53 catenin 53 Ewings sarcoma 53 PTEN gene 53 neurodegenerative disorder 53 steroidogenesis 53 medullary thyroid carcinoma 53 GIST tumors 53 systemic amyloidosis 53 malignant lesions 53 gastric atrophy 53 Chronic lymphocytic leukemia CLL 53 proteomic profiling 53 MAP kinase 53 DHFR 53 activating mutations 53 intracellular signaling 53 Acute lymphoblastic leukemia 53 histologically proven 53 Wilms Tumor 53 BRAF protein 53 metastatic renal 53 Colon polyps 53 malignancy 53 squamous cell carcinoma SCC 53 proliferation apoptosis 53 Glucocorticoids 53 diagnose coronary artery 53 mesenchymal transition 53 causative mutations 53 multidrug resistance 53 ovarian carcinoma 53 gastric lymphoma 53 NR#A# 53 bladder ovarian 53 neoplastic cells 53 proximal colon 53 pediatric acute lymphoblastic 53 excitotoxicity 53 cyclin dependent kinases CDKs 53 Bcl xL 53 HER2 overexpression 53 colorectum 53 histone deacetylases 53 PTEN protein 53 chromosomal anomaly 53 progressive neurodegenerative 53 mitochondrial toxicity 53 intimal hyperplasia 53 GPC3 53 lichen planus 53 myeloproliferative diseases 52 HDACs 52 GBM tumors 52 gallstone disease 52 CCR9 52 P. gingivalis 52 lysosomal diseases 52 acute lymphoblastic 52 osteogenic differentiation 52 susceptibility gene 52 polycythemia vera PV 52 Basal cell carcinoma 52 skeletal metastases 52 spontaneous regression 52 chromosomal rearrangement 52 T#M 52 neurological manifestations 52 nephrogenic 52 lymphangioleiomyomatosis LAM 52 NEDD9 52 regulating gene expression 52 chondrosarcoma 52 MGd 52 N Myc 52 recurrent glioblastoma multiforme 52 SOD2 gene 52 morphologic 52 lobular carcinomas 52 acute promyelocytic leukemia APL 52 epithelial ovarian 52 glioblastoma multiforme GBM 52 VCFS 52 SPINK1 52 carcinoid cancer 52 autoimmune hepatitis 52 rhabdomyosarcoma rare cancer 52 Wilms tumor 52 susceptibility locus 52 KIBRA 52 hepatocellular carcinomas 52 gastric cardia 52 malignant cancerous 52 VEGF expression 52 Chlamydia psittaci 52 radiation chemoradiation 52 microRNA miR 52 laryngeal cancer 52 malignant growths 52 ERK signaling 52 Yamanaka recipe 52 autoimmune hemolytic anemia 52 ovarian malignancy 52 gefitinib Iressa 52 Apoptosis 52 gastrointestinal stromal tumor GIST 52 Genetic Disorders 52 aneurysmal bone cyst 52 miRNA biomarkers 52 eotaxin 52 causative gene 52 neurite 52 metastatic uveal melanoma 52 polyps growths 52 airway remodeling 52 infective endocarditis 52 evolutionarily conserved 52 Thoracic Oncology Program 52 histologic 52 lymphocytic leukemia 52 cell motility 52 gene loci 52 schwannoma 52 hematopoietic cancers 52 parainfluenza virus 52 Histiocytosis 52 polycystin 52 TERT 52 fibroadenomas 52 adenocarcinomas 52 MDM2 52 medulloblastoma malignant brain tumor 52 primary cilia 52 Chronic Fatigue Syndrome CFS 52 Peritoneal mesothelioma 52 testicular cancers 52 tumor metastases 52 Chronic Lymphocytic Leukemia CLL 52 Predisposition 52 ataxia telangiectasia 52 PAOD 52 transthyretin amyloidosis 52 pro angiogenic 52 holoprosencephaly 52 endocrine tumors 52 focal adhesion kinase FAK 52 c MET 52 Monoclonal antibody 52 Flt3 52 familial adenomatous polyposis FAP 52 cyclin E 52 mTOR signaling pathway 52 castration resistant 52 pain syndromes 52 degenerative neurological diseases 52 basal cell nevus syndrome 52 tonsillar 52 choroidal melanoma 52 papillary 52 Myelodysplastic syndromes MDS 52 colorectal adenoma 52 mutant SOD1 52 ARF1 52 atherosclerotic disease 52 Cyclin D1 52 Vasculitis 52 cyclins 52 axillary node 52 Medullary thyroid cancer 52 diabetes mellitus DM 52 HBV HCV 52 chronic GVHD 52 allogeneic HSCT 52 papillary thyroid cancer 52 Synovial sarcoma 52 lymphomas 52 Lou Gehrigs disease 52 Wilm tumor 52 Chronic Myeloid Leukemia CML 52 myeloid leukemia 52 TLR3 52 microglial 52 mesenchymal cells 52 thyroid nodule 52 pathogenic mutations 52 genomic instability 52 Akt3 52 TGF b 52 preoperative staging 52 TP# mutation